Cited by 103Mitochondrial Function and PathologyAlzheimer's disease research and treatmentsAutophagy in Disease and Therapy

Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function

Open access
Orr, Adam L., Kim, Chaeyoung, Jimenez-Morales, David, Newton, Billy W., Johnson, Jeffrey R., Krogan, Nevan J., Swaney, Danielle L., Mahley, Robert W.·2019·Journal of Alzheimer's Disease

Abstract

Apolipoprotein (apo) E4, the major genetic risk factor for Alzheimer's disease (AD), alters mitochondrial function and metabolism early in AD pathogenesis. When injured or stressed, neurons increase apoE synthesis. Because of its structural difference from apoE3, apoE4 undergoes neuron-specific proteolysis, generating fragments that enter the cytosol, interact with mitochondria, and cause neurotoxicity. However, apoE4's effect on mitochondrial respiration and metabolism is not understood in detail. Here we used biochemical assays and proteomic profiling to more completely characterize the effects of apoE4 on mitochondrial function and cellular metabolism in Neuro-2a neuronal cells stably expressing apoE4 or apoE3. Under basal conditions, apoE4 impaired respiration and increased glycolysis, but when challenged or stressed, apoE4-expressing neurons had 50% less reserve capacity to generate ATP to meet energy requirements than apoE3-expressing neurons. ApoE4 expression also decreased the NAD+/NADH ratio and increased the levels of reactive oxygen species and mitochondrial calcium. Global proteomic profiling revealed widespread changes in mitochondrial processes in apoE4 cells, including reduced levels of numerous respiratory complex subunits and major disruptions to all detected subunits in complex V (ATP synthase). Also altered in apoE4 cells were levels of proteins related to mitochondrial endoplasmic reticulum-associated membranes, mitochondrial fusion/fission, mitochondrial protein translocation, proteases, and mitochondrial ribosomal proteins. ApoE4-induced bioenergetic deficits led to extensive metabolic rewiring, but despite numerous cellular adaptations, apoE4-expressing neurons remained vulnerable to metabolic stress. Our results provide insights into potential molecular targets of therapies to correct apoE4-associated mitochondrial dysfunction and altered cellular metabolism.

AI snapshot

Written from the paper’s full text.

TL;DR

In Neuro-2a cells stably expressing apoE4 versus apoE3, apoE4 impaired mitochondrial respiration and OXPHOS ATP production, increased glycolysis, and reduced spare bioenergetic capacity by about 50%. Proteomic profiling showed widespread mitochondrial and metabolic changes, including decreased respiratory complex subunits, lower NAD+/NADH, higher ROS and mitochondrial calcium, and compensatory increases in mitochondrial morphology, import, and quality-control proteins.

Key findings

  • ApoE4 cells had lower basal and FCCP-stimulated respiration, OXPHOS ATP production was 33% lower, and total reserve ATP capacity was about 50% lower than apoE3 cells; basal glycolysis was increased, but maximal glycolysis was similar, and apoE4 cells showed a greater ATP deficit under stimulated respiration only.
  • ApoE4 expression decreased the NAD+/NADH ratio and total NAD+ + NADH pool, increased intracellular ROS approximately twofold, and increased mitochondrial Ca2+ (about twofold after extracellular Ca2+ and nearly eightfold after thapsigargin), with faster mitochondrial Ca2+ influx.
  • Label-free proteomics identified approximately 4,500 proteins; over one-third differed in apoE4 cells, including 44% of 654 MitoCarta 2.0 proteins and 42% of 953 mitochondria-associated proteins. All 33 altered OXPHOS subunits were decreased, including all 12 detected complex V subunits (some by >50%); MITRAC12 was reduced by 47% and PDH E1 subunits by 20%.
  • ApoE4 cells showed increased levels of most detected MAM tethering proteins (5 of 6; GRP75 decreased), mitochondrial fusion/fission proteins, TOM/TIM import components, proteases, and all detected mitochondrial ribosomal proteins; transcription factor analyses implicated NRF1, NRF2, GABP/NRF2, E2F family members, and others.

Methods

  • Mouse neuroblastoma N2a cells stably expressing full-length apoE3 or apoE4 were used for Seahorse XF96e metabolic profiling, luciferase-based ATP measurements, NAD(H) quantification, CellROX ROS flow cytometry, and live-cell Fura-2/Rhod-2 Ca2+ imaging.
  • Label-free quantitative proteomics was performed on whole-cell lysates from three independent culture sets using LC-MS/MS, MaxQuant, and MSstats; pathway enrichment used DAVID, and transcription factor prediction used Pscan and PASTAA.
  • Sample sizes reported: Seahorse n = 6, ATP n = 4, growth n = 3, ROS n = 3, NAD(H) n = 5, Ca2+ imaging four independent experiments with 25–40 cells per group, and proteomics three independent cultures.

Limitations

  • The paper does not state limitations explicitly.
  • Evident from the text: all experiments used mouse Neuro-2a cell lines stably expressing apoE3 or apoE4, not primary neurons, animal models, or human tissue, so translational relevance is uncertain.
  • Evident from the text: label-free whole-cell proteomics reports steady-state protein levels and cannot establish causality or distinguish direct apoE4 effects from compensatory changes; acute Seahorse, ATP, and Ca2+ assays rely on pharmacologic modulators and defined media that may not reflect chronic in vivo conditions.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3233/jad-181184

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

120 of 149 cited sources checked · 62 supported · 3 flagged · accuracy not yet measured

  • Premisecitation

    In neurons, apoE4 is associated with decreased neurite outgrowth.

    “decreased neurite outgrowth”
    Quote in the paperNot a substantial claim6 of 6 sources checked
    • cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
    • cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source

      The Results report greater cell death from an apoE4 fragment in Neuro-2a cells, but do not report decreased neurite outgrowth. Searches for “neurite outgrowth” and “neurite extension” found no passage in our copy addressing that outcome. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source

      The section on mitochondrial respiratory complexes in neuronal cells reports lower levels of those complexes in apoE4-expressing neurons, but does not assess neurite outgrowth. Searches for “neurite outgrowth” and “neurite extension and neuronal process growth” found no passage addressing the claimed outcome. Page numbers were not available in our copy. (LLM, conf=0.73)

      Experimental — accuracy not yet measured
    • cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
    • cites [34] Brodbeck, 2008, Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons, Proc Natl Acad Sci U S A source

      The Results report that apoE4 reduced dendritic spine density in primary cortical neurons compared with apoE3. The introduction mentions neurite outgrowth, but our copy does not clearly state that apoE4 decreases it; spine density and neurite outgrowth are distinct measures. No page number is available in the indexed passages. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [35] Brodbeck, 2011, Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors, J Biol Chem source
  • Premisecitation

    ApoE fragments escape the secretory pathway into the cytosol.

    “The resulting apoE fragments escape the secretory pathway into the cytosol”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
    • cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source

      The Discussion (page not provided) says neuronal apoE can be cleaved into fragments and that an apoE4 fragment mislocalized to mitochondria when expressed in N2A cells. It does not say the fragments escape the secretory pathway into the cytosol; it describes mitochondrial targeting of proteolytic fragments in this study as a possibility, not an established route. (LLM, conf=0.81)

      Experimental — accuracy not yet measured
    • cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source

      The Discussion (page not available) mentions neuron-specific proteolysis and neurotoxic apoE4 fragment formation. Neither that passage nor passages retrieved for “cytosol” and “secretory pathway” say that apoE fragments leave the secretory pathway or enter the cytosol. (LLM, conf=0.74)

      Experimental — accuracy not yet measured
  • Premisecitation

    In neurons, apoE4 is associated with impaired mitochondrial respiration.

    “In neurons, apoE4 is associated with impaired mitochondrial respiration”
    Quote in the paperSubstantial claim6 of 6 sources checked
    • cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source

      The section “ApoE4 Neuropathology Independent of Aβ” (page unavailable) associates apoE4 with reduced neuronal glucose utilization and describes mitochondrial dysfunction in cultured neurons. That supports impaired mitochondrial function, but the paper does not specifically establish impaired mitochondrial respiration. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
    • cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source

      The Results report impaired mitochondrial function in Neuro-2a cells expressing truncated apoE4 fragments, measured by MitoTracker fluorescence. They do not report a direct measure of mitochondrial respiration, and the effect was observed with fragments rather than full-length apoE4. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
    • cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
    • cites [34] Brodbeck, 2008, Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons, Proc Natl Acad Sci U S A source

      The introduction (page unavailable) says that apoE4 fragments in neurons impair mitochondrial membrane potential and function, and the Results likewise describe impaired mitochondrial function. The copy does not specifically identify impaired mitochondrial respiration, so it supports the broader association but not that particular measure. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [35] Brodbeck, 2011, Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors, J Biol Chem source

      The Abstract and the section on apoE4 trafficking in mouse primary hippocampal neurons report impaired intracellular trafficking, not mitochondrial respiration. Searches for mitochondrial respiration and oxygen consumption found no passage in our copy addressing the claimed respiratory impairment. (LLM, conf=0.75)

      Experimental — accuracy not yet measured
  • Premisecitation

    In neurons, apoE4 is associated with neurotoxicity.

    “and neurotoxicity [10, 17–19, 34, 35]”
    Quote in the paperSubstantial claim6 of 6 sources checked
    • cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
    • cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
    • cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
    • cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
    • cites [34] Brodbeck, 2008, Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons, Proc Natl Acad Sci U S A source
    • cites [35] Brodbeck, 2011, Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors, J Biol Chem source
  • Premisecitation

    The largest apoE4 fragment, apoE4(1-272), causes mitochondrial fragmentation.

    “and cause mitochondrial fragmentation [10, 17, 20]”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source

      In “ApoE4 Neuropathology Independent of Aβ” (page unavailable), the paper says apoE4(1-272) accumulates in mitochondria and describes mitochondrial dysfunction associated with apoE fragments. It does not say that apoE4(1-272) causes mitochondrial fragmentation, a distinct change in mitochondrial structure. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source

      The Results report that apoE4(1-272) interacted with mitochondria in Neuro-2a cells and reduced MitoTracker fluorescence, which the authors interpret as impaired mitochondrial function and integrity. They do not report mitochondrial fragmentation; the filamentous inclusions described in the Results concern the apoE4 fragment, not mitochondrial shape. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [20] Nakamura, 2009, Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells, Mol Neurodegener source

      The Conclusion (page unavailable) reports that apoE4(1–272) expression in Neuro2a cells reduced the activities of mitochondrial respiratory complexes III and IV. This supports an effect on mitochondrial function, but the copy does not report mitochondrial fragmentation; searches for fragmentation and mitochondrial morphology found no such result. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • May combine two claims. 33
  • Classified as probably not a substantial claim. 38
  • The quote only partly states this claim. 1
  • May combine two claims.

    Premisecitation

    The largest apoE4 fragment, apoE4(1-272), interacts directly with mitochondria to reduce mitochondrial membrane potential.

    “The largest apoE4 fragment, apoE4(1–272), interacts directly with mitochondria to reduce mitochondrial membrane potential”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source

      In “ApoE4 Neuropathology Independent of Aβ” (page unavailable), the paper reports that apoE4(1–272) accumulates in mitochondria and that apoE fragments disrupt mitochondrial electropotential in cultured neurons. It does not establish that apoE4(1–272) directly binds mitochondria: the Mitochondrial Binding subsection says how the fragments associate with mitochondria is unknown and offers direct binding as one possibility. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source

      The Results report that apoE4(1–272) was found in mitochondria and that cells expressing it had 25% lower MitoTracker fluorescence than cells expressing full-length apoE4. The paper explains that MitoTracker uptake depends on normal membrane potential, but describes the result as suggesting impaired mitochondrial function and integrity; it does not directly establish a reduction in membrane potential. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [20] Nakamura, 2009, Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells, Mol Neurodegener source

      The Results section on mitochondrial membrane potential (page unavailable) reports no significant difference between Neuro2a cells expressing apoE4(1–272) and control cells, contrary to the claimed reduction. The paper does report that the fragment associates with mitochondrial proteins and reduces respiratory-complex III and IV activity, but those findings do not establish a reduction in membrane potential. (LLM, conf=0.94)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    According to the MitoCarta 2.0 database, 654 proteins were specific to or associated with mitochondria.

    “According to the MitoCarta 2.0 database [72], 654 proteins were specific to or associated with mitochondria.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [72] Calvo, 2016, MitoCarta2.0: An updated inventory of mammalian mitochondrial proteins, Nucleic Acids Res source

      The Introduction and “Human and Mouse MitoCarta2.0” section state that the MitoCarta2.0 inventory contains 1,158 human genes and 1,158 mouse genes encoding mitochondrial proteins, not 654. No page number is available in our copy. (LLM, conf=0.90)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    COX1 depletion results in defective assembly, and delivery of nuclear-encoded subunits reduces COX1 levels and also disrupts assembly.

    “COX1 depletion results in defective assembly, and delivery of nuclear-encoded subunits reduces COX1 levels and also disrupts assembly [82–87].”
    Quote in the paperNot a substantial claim4 of 6 sources checked
    • cites [82] Dennerlein, 2015, Human mitochondrial COX1 assembly into cytochromeoxidase at a glance, J Cell Sci source
    • cites [83] Diaz, 2010, Cytochrome c oxidase deficiency: Patients and animal models, Biochim Biophys Acta source

      Section 3.3.1 describes COX1 as the first assembly intermediate, supporting the link between COX1 depletion and defective assembly. Section 3.3 says assembly factors help transport nuclear-encoded subunits, but neither passage says that their delivery reduces COX1 levels; section 5.2 instead links impaired COX1 synthesis to a TACO1 mutation. Page numbers are unavailable in our copy. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [84] Mick David, 2012, MITRAC links mitochondrial protein translocation to respiratory-chain assembly and translational regulation, Cell source

      The Results (page unavailable) report that MITRAC12 depletion reduces COX1 synthesis and the amount of newly synthesized COX1 in mature cytochrome c oxidase, supporting a link between COX1 loss and impaired assembly. They also show that TIM21 promotes assembly of an imported nuclear-encoded subunit. But the paper does not show that delivery of those subunits reduces COX1 levels; its Discussion describes reduced COX1 translation when the supply of imported subunits is limited, in yeast. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [85] Richter-Dennerlein, 2016, Mitochondrial protein synthesis adapts to influx of nuclear-encoded protein, Cell source

      In Results, ‘Defects in COX1 Assembly Cause Accumulation of a Ribosome Nascent Chain Complex’ (page unavailable), the paper reports decreased COX1 and loss of functional complex IV when the nuclear-encoded subunit COX4 was depleted. The claim reverses that condition: it says delivery of nuclear-encoded subunits reduces COX1 and disrupts assembly, whereas the reported effect followed COX4 depletion. (LLM, conf=0.86)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [86] Richter-Dennerlein, 2015, Integrating mitochondrial translation into the cellular context, Nat Rev Mol Cell Biol source
    • cites [87] Barrientos, 2009, Suppression mechanisms of COX asbly defects in yeast and human: Insights into the COX assembly process, Biochim Biophys Acta source

      Section 2.4 reports that Cox1p synthesis is down-regulated in yeast when its assembly partners are absent, and that reduced Cox1p synthesis accompanies failed COX assembly. It does not say that delivery of nuclear-encoded subunits reduces COX1 levels; the reported relationship concerns the absence of assembly partners, not their delivery. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    Apolipoprotein E4 is the major genetic risk factor for Alzheimer's disease.

    “Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer’s disease (AD)”
    Quote in the paperSubstantial claim1 of 3 sources checked
    • cites [1] Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science source
    • cites [2] Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis, J Am Med Assoc source
    • cites [3] Genin, 2011, APOE and Alzheimer disease: A major gene with semi-dominant inheritance, Mol Psychiatry source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    ApoE4 occurs in approximately two-thirds of all Alzheimer's disease cases.

    “occurs in approximately two-thirds of all cases [1–3]”
    Quote in the paperNot a substantial claim1 of 3 sources checked
    • cites [1] Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science source
    • cites [2] Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis, J Am Med Assoc source
    • cites [3] Genin, 2011, APOE and Alzheimer disease: A major gene with semi-dominant inheritance, Mol Psychiatry source

      The Introduction reports that APOE4 is enriched among Alzheimer’s disease patients, and the Results say genotype frequencies were estimated for cases. Neither passage gives a two-thirds figure for cases; the Discussion’s 0.09–0.30 figure concerns allele frequency in human populations, not the proportion of patients carrying APOE4. Page numbers are unavailable in our copy. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    ApoE4 lowers the age of onset of Alzheimer's disease.

    “lowers the age of onset [4–14]”
    Quote in the paperNot a substantial claim9 of 10 sources checked
    • cites [4] Biundo, 2015, Interaction of apoE3 and apoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory, Neurobiol Learn Mem source
    • cites [5] Bu, 2009, Apolipoprotein E and its receptors in Alzheimer’s disease: Pathways, pathogenesis and therapy, Nat Rev Neurosci source

      The Introduction identifies ApoE ε4 as a major risk factor for late-onset Alzheimer’s disease and says its effect on risk is greatest between ages 60 and 70. It does not state that carriers develop Alzheimer’s at a younger age than noncarriers, so the specific age-of-onset claim goes beyond what the copy reports. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
    • cites [6] Holtzman, 2012, Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease, Cold Spring Harb Perspect Med source
    • cites [7] Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell source
    • cites [8] Kim, 2009, The role of apolipoprotein E in Alzheimer’s disease, Neuron source
    • cites [9] Liu, 2013, Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy, Nat Rev Neurol source
    • cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
    • cites [11] Mahley, 2009, Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS, J Lipid Res source

      The Historical Background section identifies ApoE4 as a major genetic risk factor for Alzheimer’s disease, and the Neurodegenerative Disorders section describes its contribution to AD neuropathology. Neither passage states that ApoE4 lowers the age of AD onset; searches for age of onset and earlier onset found no such statement in our copy. Page numbers were not available. (LLM, conf=0.77)

      Experimental — accuracy not yet measured
    • cites [12] Mahley, 2012, Apolipoprotein E sets the stage: Response to injury triggers neuropathology, Neuron source
    • cites [13] Mahley, 2012, Small-molecule structure correctors target abnormal protein structure and function: The structure corrector rescue of apolipoprotein E–associated neuropathology, J Med Chem source
  • Classified as probably not a substantial claim.

    Premisecitation

    Cell-specific toxicity is the result of neuron-specific apoE4 proteolysis.

    “Cell-specific toxicity is the result of neuron-specific apoE4 proteolysis [7, 12].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [7] Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell source

      In the ApoE4 section, the paper says apoE4 proteolysis generates neurotoxic fragments in neurons but not astrocytes. It calls this “one potential mechanism” for the cell-source-dependent effects, so the claim overstates the certainty of the causal link. No page number is supplied in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [12] Mahley, 2012, Apolipoprotein E sets the stage: Response to injury triggers neuropathology, Neuron source
  • May combine two claims.

    Premisecitation

    ApoE fragments interact directly with mitochondria and disrupt their function.

    “Although apoE fragments interact directly with mitochondria and disrupt their function [17, 20]”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
    • cites [20] Nakamura, 2009, Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells, Mol Neurodegener source
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Compelling evidence links neurodegeneration to altered brain metabolism and mitochondrial dysfunction, both of which are early hallmarks of Alzheimer's disease.

    “Compelling evidence links neurodegeneration to altered brain metabolism and mitochondrial dysfunction, both of which are early hallmarks of AD [21–28].”
    Quote in the paperSubstantial claim4 of 8 sources checked
    • cites [21] Minoshima, 1997, Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease, Ann Neurol source

      The Discussion reports severe metabolic reduction in the posterior cingulate cortex at a very early stage of Alzheimer’s disease and discusses a possible link to neural degeneration. It does not establish mitochondrial dysfunction as an early hallmark; its discussion of cytochrome oxidase concerns neuronal activity, not a finding of mitochondrial dysfunction. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [22] Kish, 1992, Brain cytochrome oxidase in Alzheimer’s disease, J Neurochem source
    • cites [23] Maurer, 2000, A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, Neurobiol Aging source
    • cites [24] Liang, 2008, Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons, Proc Natl Acad Sci U S A source
    • cites [25] Moreira, 2018, Sweet mitochondria: A shortcut to Alzheimer’s disease, J Alzheimers Dis source

      The Introduction describes metabolic defects as characteristic of sporadic AD, and Author Views and Conclusions links defective brain glucose metabolism and mitochondrial anomalies to AD and neurodegeneration. That section also says mitochondrial defects seem to play an early role in AD development, but our copy does not establish that altered brain metabolism is likewise an early hallmark. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [26] Selfridge, 2013, Role of mitochondrial homeostasis and dynamics in Alzheimer’s disease, Neurobiol Dis source
    • cites [27] Reddy, 2012, Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: Implications to mitochondria-targeted antioxidant therapeutics, Biochim Biophys Acta source

      Section 3.1 reports reduced brain glucose metabolism in AD, and sections 3 and 4.0 link mitochondrial dysfunction to AD pathology, including early deficits in a mouse model. The paper does not establish that altered brain metabolism itself is an early hallmark of AD; its glucose-metabolism passage does not address timing. No page numbers are available in our copy. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [28] Onyango, 2017, Mitochondria in the pathophysiology of Alzheimer’s and Parkinson’s diseases, Front Biosci source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Alterations in the integrity of mitochondria-ER-associated membranes have been linked to processes underlying dementia.

    “Alterations in the integrity of MAM have been linked to processes underlying dementia [47–49].”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [47] Paillusson, 2016, There’s something wrong with my MAM; the ER–mitochondria axis and neurodegenerative diseases, Trends Neurosci source
    • cites [48] Area-Gomez, 2018, A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease, Cell Death Dis source
    • cites [49] Schon, 2011, Mitochondria: The next (neurode)generation, Neuron source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The aberrant proteolytic processing of apoE4 and consequent neurotoxicity can be blocked by treating apoE4-expressing cells with small-molecule structure correctors, which convert apoE4 to an apoE3-like conformation and prevent apoE4 fragment generation.

    “The aberrant proteolytic processing of apoE4 and consequent neurotoxicity can be blocked by treating apoE4-expressing cells with small-molecule “structure correctors,” which convert apoE4 to an apoE3-like conformation and prevent apoE4 fragment generation [12, 13, 18, 19].”
    Quote in the paperNot a substantial claim4 of 4 sources checked
    • cites [12] Mahley, 2012, Apolipoprotein E sets the stage: Response to injury triggers neuropathology, Neuron source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
    • cites [13] Mahley, 2012, Small-molecule structure correctors target abnormal protein structure and function: The structure corrector rescue of apolipoprotein E–associated neuropathology, J Med Chem source

      Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
    • cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
    • cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    ApoE fragments engage in abnormal interactions in the cytosol that lead to neurodegeneration.

    “where they engage in abnormal interactions that lead to neurodegeneration [17–19]”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
    • cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source

      The Discussion (page not available in our copy) reports that an apoE4 fragment can bind mitochondrial respiratory-complex subunits and impair their activity. It does not place those interactions in the cytosol or establish that the fragment interactions lead to neurodegeneration; the paper links neurodegeneration more broadly to apoE4 domain interaction. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source

      The Discussion (page unavailable) identifies neurotoxic apoE4 fragment formation among apoE4’s neuropathological features, and describes an abnormal interaction between domains of apoE4. It does not say that the fragments engage in abnormal interactions in the cytosol or that those interactions lead to neurodegeneration. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Mitochondria are involved in neuronal redox homeostasis, reactive oxygen species production, calcium buffering, and intracellular signaling.

    “Mitochondria are also involved in neuronal redox homeostasis, reactive oxygen species (ROS) production, calcium buffering, and intracellular signaling [41–44].”
    Quote in the paperNot a substantial claim3 of 4 sources checked
    • cites [41] Spinelli, 2018, The multifaceted contributions of mitochondria to cellular metabolism, Nat Cell Biol source

      The sections “Mitochondria balance redox equivalents” and “ROS” describe mitochondrial roles in cellular redox balance, ROS production, and signaling (page numbers unavailable). They do not establish these roles specifically in neurons, and the searched passages do not address calcium buffering. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [42] Giorgi, 2018, The machineries, regulation and cellular functions of mitochondrial calcium, Nat Rev Mol Cell Biol source

      The review describes mitochondrial calcium buffering in neurons (Mitochondria in Ca²⁺ Homeostasis, p. 11), links mitochondrial calcium handling to ROS generation (p. 12), and describes a role in cellular calcium signaling (Introduction, p. 4). It does not establish the claim about neuronal redox homeostasis specifically; its redox discussion is not framed as a neuronal finding. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [43] Angelova, 2018, Role of mitochondrial ROS in the brain: From physiology to neurodegeneration, FEBS Lett source
    • cites [44] Shadel, 2015, Mitochondrial ROS signaling in organismal homeostasis, Cell source

      The “Mitochondrial ROS Signaling” section describes mitochondrial ROS production and redox signaling, while the brain-focused sections discuss mitochondrial ROS control in neurons. “Mitochondria and Associated Homeostatic and Stress Signaling Pathways” also names ion homeostasis, but the passages do not establish the more specific claim of neuronal calcium buffering. Page numbers were not available in our copy. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Many mitochondrial proteins must be assembled into large, multi-subunit structures, some of which form supercomplexes that are essential for mitochondrial energy metabolism.

    “many must be assembled into large, multi-subunit structures, some of which form “supercomplexes” [39] that are essential for mitochondrial energy metabolism [40]”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [39] Letts, 2016, The architecture of respiratory supercomplexes, Nature source
    • cites [40] Ikeda, 2013, A stabilizing factor for mitochondrial respiratory supercomplex assembly regulates energy metabolism in muscle, Nat Commun source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Mitochondria communicate with the rest of the cell by metabolite shuttling, direct interactions with other organelles, and altered proteostasis.

    “Mitochondria communicate with the rest of the cell by metabolite shuttling, direct interactions with other organelles, and altered proteostasis [36, 37].”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [36] Chandel, 2014, Mitochondria as signaling organelles, BMC Biol source
    • cites [37] Pellegrino, 2013, Signaling the mitochondrial unfolded protein response, Biochim Biophys Acta source

      Section 5 describes a pathway in which mitochondrial protein-folding stress is transmitted to the nucleus, supporting communication through altered proteostasis. The passages do not describe metabolite shuttling or direct interactions with other organelles as communication routes. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Direct interactions between mitochondria and the endoplasmic reticulum, particularly at mitochondria-ER-associated membranes, allow direct calcium exchange between the organelles and facilitate lipid synthesis, exchange, and metabolism.

    “direct interactions between mitochondria and the endoplasmic reticulum (ER), particularly at mitochondria–ER-associated membranes (MAM), allow direct calcium exchange between the organelles and facilitate lipid synthesis, exchange, and metabolism [45, 46]”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [45] van Vliet, 2014, New functions of mitochondria associated membranes in cellular signaling, Biochim Biophys Acta source
    • cites [46] Hayashi, 2009, MAM: More than just a housekeeper, Trends Cell Biol source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Extra-mitochondrial Ca2+ enters the mitochondria via outer membrane voltage-dependent anion channels (VDACs) and the mitochondrial Ca2+ uniporter on the inner membrane.

    “Extra-mitochondrial Ca2+ enters the mitochondria via outer membrane voltage-dependent anion channels (VDACs) and the mitochondrial Ca2+ uniporter on the inner membrane [71].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [71] Brisac, 2010, Calcium flux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis, J Virol source

      The Results and Discussion state that mitochondrial Ca2+ uptake occurs through VDAC and the Ca2+ uniporter, and report inhibition of uptake when either channel is blocked in poliovirus-infected IMR5 cells. Our copy does not explicitly locate VDAC in the outer membrane or the uniporter in the inner membrane, so it does not support that part of the sentence. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Previously, the authors reported deficits in single subunits of each of the OXPHOS complexes in apoE4-expressing neuronal cells.

    “Previously, we reported deficits in single subunits of each of the OXPHOS complexes in the apoE4-expressing neuronal cells [18].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Disruption of the communication networks between mitochondria and the rest of the cell is thought to contribute to aging and neurodegeneration.

    “Disruption of the communication networks between mitochondria and the rest of the cell is thought to contribute to aging and neurodegeneration [50, 51].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [50] source

      Not checked in the free run.

    • cites [51] Carvalho, 2009, Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia, J Bioenerg Biomembr source

      The “Mitochondria and the brain” section (page unavailable) says that excess reactive oxygen species activate anomalous signaling and discusses mitochondrial damage during aging. The “Is mitochondrial dysfunction a necessary step in neurodegeneration?” section (page unavailable) links mitochondrial dysfunction to Alzheimer’s disease. The copy does not specifically say that disrupted communication between mitochondria and the rest of the cell contributes to aging. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim.

    Premisecitation

    Normal respiration requires the coordinated production of subunits for proper assembly into functional complexes.

    “Normal respiration requires the coordinated production of subunits for proper assembly into functional complexes [81].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [81] Fernández-Vizarra, 2009, Assembly of the oxidative phosphorylation system in humans: What we have learned by studying its defects, Biochim Biophys Acta source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Thapsigargin-induced Ca2+ transfer from the ER to mitochondria depends on IP3R in the ER and VDACs on the outer mitochondrial membrane.

    “Furthermore, thapsigargin-induced Ca2+ transfer from the ER to mitochondria depends on IP3R in the ER and VDACs on the outer mitochondrial membrane [93, 94].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [93] Deniaud, 2008, Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis, Oncogene source
    • cites [94] Bravo, 2012, Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics, Int J Biochem Cell Biol source

      Section 2.2 identifies IP3R and VDAC as the main ER–mitochondria Ca2+ transfer channels on the ER and mitochondrial sides, respectively. Section 3 describes mitochondrial uptake of Ca2+ released through ER-localized IP3R. The copy does not establish that thapsigargin-induced transfer specifically depends on both channels. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Respiratory complexes consist of 13 subunits encoded by mitochondrial DNA and 78 encoded by nuclear DNA.

    “Respiratory complexes consist of 13 subunits encoded by mitochondrial DNA and 78 encoded by nuclear DNA [80].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [80] Signes, 2018, Assembly of mammalian oxidative phosphorylation complexes I–V and supercomplexes, Essays Biochem source

      The Introduction and the sections on complexes I, III, IV and V describe subunits encoded by mitochondrial and nuclear DNA; their accounts identify seven, one, three and two mitochondrial-encoded subunits, respectively, supporting the total of 13. Our copy does not state a total of 78 nuclear-encoded subunits, so that number is not verified. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    MAM participate in lipid synthesis, membrane stability, mitochondrial dynamics, and ROS signaling.

    “Besides controlling Ca2+ flux, MAM participate in lipid synthesis, membrane stability, mitochondrial dynamics, and ROS signaling [99–101].”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [99] Rowland, 2012, Endoplasmic reticulum–mitochondria contacts: Function of the junction, Nat Rev Mol Cell Biol source

      The “Lipid exchange during biosynthesis” section says the MAM fraction is enriched in lipid-synthesis enzymes, and “Regulating mitochondrial dynamics and inheritance” links ER–mitochondria contacts to mitochondrial dynamics. The passages do not establish membrane stability or ROS signaling as functions of MAM. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [100] Phillips, 2016, Structure and function of ER membrane contact sites with other organelles, Nat Rev Mol Cell Biol source

      The ER–mitochondria section on lipid biosynthesis and exchange describes phospholipid synthesis and transfer at the contact interface; the Organelle biogenesis > ER–mitochondria section says contact sites help position mitochondrial fission. The passages located do not establish a role in membrane stability or ROS signaling. The discussion of stability in “MCS-bound organelles in motion” concerns the stability of contact sites, not membranes; page numbers are unavailable in our copy. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [101] Rieusset, 2018, The role of endoplasmic reticulum-mitochondria contact sites in the control of glucose homeostasis: An update, Cell Death Dis source

      The Inter-organelle signalling section describes lipid synthesis and exchange at MAMs and ROS-mediated signalling. The Metabolic interplay section links MAMs to mitochondrial dynamics. Neither section establishes a role in membrane stability; the paper’s references to MAM integrity concern ER–mitochondria contacts, not membrane stability. Page numbers were unavailable in our copy. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    These factors, including nuclear respiratory factor 1, nuclear factor erythroid-2-like 2, GA binding protein (nuclear respiratory factor 2), and Sp4, directly and indirectly control the expression of respiratory chain subunits encoded by nuclear and mitochondrial DNA.

    “These factors, including nuclear respiratory factor 1, nuclear factor erythroid-2-like 2, GA binding protein (nuclear respiratory factor 2), and Sp4 [110–114] directly and indirectly control the expression of respiratory chain subunits encoded by nuclear and mitochondrial DNA [110, 115, 116].”
    Quote in the paperNot a substantial claim5 of 7 sources checked
    • cites [110] Scarpulla, 2005, Nuclear control of respiratory gene expression in mammalian cells, J Cell Biochem source
    • cites [111] Ohtsuji, 2008, Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes, J Biol Chem source

      The Abstract (page not available) identifies Nrf2 as a transcription factor that regulates antioxidant and xenobiotic-metabolizing genes, supporting its inclusion among the named factors. The paper does not establish that these factors control respiratory-chain subunits encoded by nuclear or mitochondrial DNA; searches for respiratory-chain and mitochondrial terms returned no such passage. Its Nrf1 is a Cap’n’Collar factor, not the nuclear respiratory factor 1 named in the claim. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [112] Yang, 2014, GABP transcription factor (nuclear respiratory factor 2) is required for mitochondrial biogenesis, Mol Cell Biol source
    • cites [113] Holmström, 2016, The multifaceted role of Nrf2 in mitochondrial function, Curr Opin Toxicol source

      The “Nrf2 and mitochondrial homeostasis” section reports that Nrf2 stimulates mitochondrial biogenesis through activation of nuclear respiratory factor 1. The stem-cell section also describes Nrf2 activating Pitx2, which then activates components of the electron transport chain. These passages support an indirect role for Nrf2, but do not establish the stated direct and indirect control of respiratory-chain subunit genes encoded by both nuclear and mitochondrial DNA, or address GA binding protein and Sp4. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [114] Dinkova-Kostova, 2015, The emerging role of Nrf2 in mitochondrial function, Free Radic Biol Med source

      The “Nrf2 and mitochondrial biogenesis” section (page unavailable) says nuclear respiratory factors 1 and 2 control genes encoding respiratory-complex subunits, and that Nrf2 can promote mitochondrial biogenesis through nuclear respiratory factor 1. The copy also reports Nrf2-associated changes in respiratory-chain proteins. It does not establish the claimed role for Sp4 or show that these factors control expression of subunits encoded by mitochondrial DNA. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [115] Dhar, 2008, Nuclear respiratory factor 1 regulates all ten nuclear-encoded subunits of cytochrome c oxidase in neurons, J Biol Chem source
    • cites [116] Johar, 2013, Neuron-specific specificity protein 4 bigenomically regulates the transcription of all mitochondria- and nucleus-encoded cytochrome c oxidase subunit genes in neurons, J Neurochem source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Increased tethering may be associated with neurodegeneration, including the risk of AD.

    “Increased tethering may be associated with neurodegeneration, including the risk of AD [103].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [103] Schon, 2013, Mitochondria-associated ER membranes in Alzheimer disease, Mol Cell Neurosci source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Fission/fusion processes help modulate mitochondrial function in both normal and pathological conditions.

    “Fission/fusion processes help modulate mitochondrial function in both normal and pathological conditions [105].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [105] Youle, 2012, Mitochondrial fission, fusion, and stress, Science source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Other important MAM tethering proteins are B-cell receptor-associated protein 31, mitochondrial fission 1 protein, and mitofusin.

    “Other important MAM tethering proteins are B-cell receptor–associated protein 31, mitochondrial fission 1 protein [96], and mitofusin [97].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [96] Iwasawa, 2011, Fis1 and Bap31 bridge the mitochondria–ER interface to establish a platform for apoptosis induction, EMBO J source
    • cites [97] de Brito, 2008, Mitofusin 2 tethers endoplasmic reticulum to mitochondria, Nature source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    IP3R and VDACs are MAM components that tether the ER to mitochondria through the molecular chaperone GRP75.

    “IP3R and VDACs are MAM components that tether the ER to mitochondria through the molecular chaperone GRP75 [95].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [95] Szabadkai, 2006, Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels, J Cell Biol source

      The ER–mitochondria interface section reports IP3R, VDAC1 and grp75 in the MAM fraction and a shared complex, with grp75 proposed to scaffold the two channels. The Discussion calls grp75 the key assembling molecule in their loose interaction. This supports channel coupling at the interface, but does not establish that the complex physically tethers the ER and mitochondria. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    When forced to use mitochondria to generate ATP, both cell lines grew slower than under basal conditions, but the slowing was significantly greater in apoE4-expressing cells.

    “When forced to use mitochondria to generate ATP, both cell lines grew slower than under basal conditions, a response common in cells restricted to grow only on mitochondrial energy production [66]; however, the slowing was significantly greater in the apoE4-expressing cells.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    ApoE4 expression altered the levels of 44% of MitoCarta mitochondrial proteins, with similar numbers significantly increased or decreased.

    “ApoE4 expression altered the levels of 44% of these proteins; similar numbers were significantly increased or decreased.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • May combine two claims.

    Findingown data

    There were significant alterations in NADH shuttle components, NAD(P)-dependent metabolic enzymes, numerous cytosolic and mitochondrial antioxidant enzymes, and the NAD synthetic enzyme NAMPT in apoE4 cells.

    “For example, there were significant alterations in NADH shuttle components (components of both malate-aspartate and glycerol phosphate shuttles), NAD(P)-dependent metabolic enzymes [NAD(P)-dehydrogenase (which converts NADH into NADPH)], numerous cytosolic and mitochondrial antioxidant enzymes, and the NAD synthetic enzyme NAMPT (Fig. 6).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • May combine two claims.

    Findingown data

    Over one-third of detected proteins differed in expression between apoE4 and apoE3 cells, with similar numbers significantly increased or decreased.

    “Over one-third differed in their expression in apoE4 versus apoE3 cells; similar numbers of proteins were significantly increased or decreased (p < 0.05).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • The quote only partly states this claim.

    Findingown data

    Mitochondrial Ca2+ levels 8 min after extracellular Ca2+ addition were twofold higher in apoE4-expressing cells than in apoE3-expressing cells.

    “In contrast, in response to extracellular Ca2+, both the basal mitochondrial Ca2+ level (Fig. 4E) and the rate of Ca2+ influx into mitochondria in response to extracellular Ca2+ were much greater in cells expressing apoE4 (Fig. 4F, H), culminating in twofold higher levels of mitochondrial Ca2+ (Fig. 4G).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Pathways enriched with proteins significantly increased by apoE4 were strongly related to RNA-related processes, whereas pathways enriched with proteins significantly decreased by apoE4 were heavily involved in OXPHOS, including ATP binding, ATP metabolic processes, ATP synthesis, and metabolism.

    “Broadly speaking, in addition to mitochondrion and mitochondrial inner membrane proteins, pathways enriched with proteins significantly increased by apoE4 were strongly related to RNA-related processes, whereas pathways and processes enriched with proteins significantly decreased by apoE4 were heavily involved in OXPHOS, including ATP binding, ATP metabolic processes, ATP synthesis, and metabolism”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • May combine two claims.

    Findingown data

    The levels of 42% of the 953 mitochondria-associated proteins were significantly changed by apoE4 expression, with equal numbers increased and decreased.

    “Using the MitoMiner 4.0 database [73] and the Gene Ontology “Mitochondrion” category [74, 75], we identified 953 proteins associated with mitochondria; the levels of 42% of those proteins were significantly changed by apoE4 expression, again with equal numbers increased and decreased (Fig. 5A).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • May combine two claims.

    Findingown data

    When mitochondria were forced to produce ATP from pyruvate oxidation in the absence of glucose (stimulated respiration only), total ATP levels decreased markedly in both cell lines, but apoE4-expressing cells had a small, significantly greater deficit in energy levels.

    “However, when the mitochondria were forced to produce ATP from pyruvate oxidation in the absence of glucose (stimulated respiration only), total ATP levels decreased markedly in both cell lines, but the apoE4-expressing cells had a small, but significantly greater deficit in energy levels (Fig. 2A).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The levels of all 33 subunits altered by apoE4 were significantly decreased, as was the level of cytochrome c.

    “Remarkably, the levels of all 33 subunits altered by apoE4 were significantly decreased (p < 0.05), as was the level of cytochrome c.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Lists of proteins significantly increased (501 proteins) or decreased (606 proteins) at a p < 0.01 threshold were queried together to identify transcription factors most likely to drive coordinated changes in protein expression in N2a-apoE4 cells.

    “lists of proteins significantly increased (501 proteins) or decreased (606 proteins) at a p < 0.01 threshold were queried together to identify the transcription factors most likely to drive the coordinated changes in protein expression in N2a-apoE4 cells”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Proteomic analysis revealed a remarkable reduction in the levels of 50% of detected subunits of mitochondrial respiratory complexes I-V; none were increased.

    “Proteomic analysis revealed a remarkable reduction in the levels of 50% of detected subunits of mitochondrial respiratory complexes I–V; none were increased.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • May combine two claims.

    Findingown data

    Although the cytosolic Ca2+ level did not differ between apoE3- and apoE4-expressing cells at 8 min, the rate of cytosolic Ca2+ influx was twofold higher in apoE4 cells.

    “Although the cytosolic Ca2+ level did not differ between apoE3- and apoE4-expressing cells at 8 min (Fig. 4C), the rate of cytosolic Ca2+ influx was twofold higher in apoE4 cells (Fig. 4D).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Of six detected MAM tethering proteins, the levels of five were increased in apoE4-expressing cells and the level of one (GRP75) was decreased.

    “Of six detected tethering proteins, the levels of five were increased in apoE4-expressing cells and the level of one (GRP75) was decreased (Fig. 8B).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    A total of 65 OXPHOS subunits plus cytochrome c were detected.

    “A total of 65 subunits plus cytochrome c were detected (Fig. 7A).”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • May combine two claims.

    Findingown data

    Associated with impaired mitochondrial activity were a decreased NAD+/NADH ratio and increased levels of mitochondrial Ca2+ and cellular ROS.

    “Associated with the impaired mitochondrial activity were a decreased NAD+/NADH ratio and increased levels of mitochondrial Ca2+ and cellular ROS.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Live-cell imaging showed an increase in mitochondrial Ca2+ and faster mitochondrial Ca2+ uptake during thapsigargin-induced Ca2+ release from the ER.

    “Live-cell imaging showed an increase in mitochondrial Ca2+ and faster mitochondrial Ca2+ uptake during thapsigargin-induced Ca2+ release from the ER.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The levels of all 12 subunits detected in complex V (ATP synthase) were decreased, some by greater than 50%.

    “Most strikingly, the levels of all 12 subunits detected in complex V (ATP synthase) were decreased, some by greater than 50% (Fig. 7B).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • May combine two claims.

    Findingown data

    Numerous proteins linked to mitochondrial morphology and to the synthesis, import, maturation, and degradation of mitochondrial proteins were coordinately changed in apoE4 cells, with most proteins in these pathways showing increased expression.

    “Numerous proteins linked to mitochondrial morphology and to the synthesis, import, maturation, and degradation of mitochondrial proteins were also coordinately changed in apoE4 cells, with most proteins in these pathways showing increased expression (Fig. 9).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • May combine two claims.

    Findingown data

    The levels of the translocases of both the outer and inner mitochondrial membrane (the TOM and TIM complexes) and three of four TOM-associated factors were increased in apoE4 cells.

    “Also increased were levels of the translocases of both the outer and inner mitochondrial membrane (the TOM and TIM complexes), which control the delivery of cytosolic proteins to the mitochondria, and three of four TOM-associated factors [106].”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
    • Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The vast majority of mitochondrial proteins require import, proteolytic maturation, and delivery to the correct submitochondrial compartment.

    “the vast majority of mitochondrial proteins require import, proteolytic maturation, and delivery to the correct submitochondrial compartment [38]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [38] Rampelt, 2016, Coordination of two genomes by mitochondrial translational plasticity, Cell source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    ApoE4 differs from apoE3 by a single amino acid.

    “ApoE4 differs from apoE3 by a single amino acid [15]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [15] Mahley, 1988, Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology, Science source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Protein content did not differ in equivalent numbers of N2a-apoE3 and N2a-apoE4 cells.

    “Protein content did not differ in equivalent numbers of N2a-apoE3 and N2a-apoE4 cells.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    ApoE4 expression impairs mitochondrial energy production, leading to metabolic inflexibility and inability to respond to metabolic demand.

    “Thus, apoE4 expression impairs mitochondrial energy production, leading to metabolic inflexibility and inability to respond to metabolic demand.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Mitochondria in apoE4 cells have a higher resting level of Ca2+ and accumulate Ca2+ faster and to higher levels.

    “Thus, mitochondria in apoE4 cells have a higher resting level of Ca2+ and accumulate Ca2+ faster and to higher levels.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    All peptide and protein identifications were filtered to a 1% false-discovery rate.

    “all peptide and protein identifications were filtered to a 1% false-discovery rate”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Titration of metabolic modulators was performed to ensure no differential sensitivities existed between N2a-apoE3 and N2a-apoE4 cells and that fully inhibited or stimulated rates were always obtained for each Seahorse run.

    “Titration of metabolic modulators was performed to ensure no differential sensitivities existed between N2a-apoE3 and N2a-apoE4 cells and that fully inhibited or stimulated rates were always obtained for each Seahorse run.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Mitochondrial Ca2+ overload in apoE4-expressing neurons promotes mitochondrial impairment and neurodegeneration.

    “Our findings on Ca2+ fluxes imply that mitochondrial Ca2+ overload in apoE4-expressing neurons promotes mitochondrial impairment and neurodegeneration.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    ApoE4-expressing cells appear to lack both the capacity to meet high levels of energy demand and the metabolic flexibility to respond to stress.

    “apoE4-expressing cells appear to lack both the capacity to meet high levels of energy demand and the metabolic flexibility to respond to stress”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Three independent sets of cultures were harvested separately but processed in parallel for LC-MS/MS analysis.

    “Three independent sets of cultures were harvested separately but processed in parallel for LC-MS/MS analysis.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Interpretationreasoning

    The initiating event may involve disruptions in the production/delivery of OXPHOS subunits and the assembly of the OXPHOS complexes.

    “The initiating event may involve disruptions in the production/delivery of OXPHOS subunits and the assembly of the OXPHOS complexes.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationreasoning

    These changes could reflect an attempt to restore normal mitochondrial function.

    “These changes could reflect an attempt to restore normal mitochondrial function.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Increased expression of mitofusin enhances the interaction between VDAC1 and IP3R.

    “Increased expression of mitofusin enhances the interaction between VDAC1 and IP3R [98].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [98] Tubbs, 2014, Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance, Diabetes source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Increased expression of MAM proteins enhances tethering between the organelles and modulates connectivity/conductivity.

    “Increased expression of MAM proteins enhances tethering between the organelles and modulates connectivity/conductivity [102].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [102] Naon, 2014, At the right distance: ER-mitochondria juxtaposition in cell life and death, Biochim Biophys Acta source
61 of 61
  • The paper relies on this without support.

    The extent to which apoE4 disrupts mitochondrial function and cellular metabolism in neurons remains poorly defined.

    “the extent to which apoE4 disrupts mitochondrial function and cellular metabolism in neurons remains poorly defined”
  • The paper relies on this without support.

    ApoE4’s effect on mitochondrial respiration and metabolism is not understood in detail.

    “apoE4’s effect on mitochondrial respiration and metabolism is not understood in detail”
  • The paper relies on this without support.

    When injured or stressed, neurons increase apoE synthesis.

    “When injured or stressed, neurons increase apoE synthesis.”
  • The paper relies on this without support.

    Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.

    “ApoE4 altered a wide range of proteins involved in OXPHOS, redox homeostasis, and glucose and amino acid metabolism (Fig. 6).”
  • The paper relies on this without support.

    The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.

    “Label-free, quantitative proteomic profiling of whole-cell lysates from N2a-apoE3 and N2a-apoE4 cells by LC-MS/MS identified approximately 4500 distinct proteins (Fig. 5A).”
  • The paper relies on this without support.

    Complex IV assembly requires the MITRAC assembly complex.

    “For example, complex IV assembly requires the MITRAC assembly complex, a central component of which, MITRAC12, was reduced by 47% in apoE4-expressing cells (p < 1×10–9).”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Impaired calcium flux has been observed in vitro in an APOE4-expressing neuronal cell line compared with an APOE3-expressing line and could be partially responsible for the hyperexcitability seen in APOE4 neurons in culture.

    “Impaired calcium flux has been observed in vitro in an APOE4-expressing neuronal cell line compared with an APOE3-expressing line and could be partially responsible for the hyperexcitability seen in APOE4 neurons in culture173.”

    From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [173]

    The Results section (page unavailable) reports altered calcium flux in cultured N2a-apoE4 cells compared with N2a-apoE3 cells, including faster mitochondrial calcium uptake. The cited paper does not establish or propose that this alteration contributes to hyperexcitability in APOE4 neurons; its Discussion instead links mitochondrial calcium overload to mitochondrial impairment and neurodegeneration. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • APOE-dependent alterations in mitochondrial fusion/fission protein levels have been shown in other studies; however, those were contradictory.

    “In contrast, APOE-dependent alterations in mitochondrial fusion/fission protein levels have been shown in other studies; however, those were contradictory.”

    From APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons (2024) · cites this paper as [33]

    The Results (Fig. 9; page unavailable) and Discussion report that apoE4 altered levels of mitochondrial fusion/fission proteins in this study. They do not say that other studies found such alterations or that those studies contradicted one another. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • ApoE4 (272-299 aa fragment) increases ROS levels in N2a cell line.

    “ApoE4 (272–299 aa fragment) was demonstrated to increase ROS levels in N2a cell line [28,73]”

    From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [73]

    The Results (Fig. 3B; page unavailable) report approximately twofold higher ROS levels in N2a cells expressing apoE4 than in cells expressing apoE3. But Materials and Methods (Cell lines; page unavailable) specifies full-length apoE4, not a 272–299 amino-acid fragment, so the fragment-specific claim is not supported. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • APOE4 N2A cells expressed higher levels of fission and fusion proteins than APOE3 N2A cells.

    “MFN1, MFN2, OPA1, and FIS1 levels were decreased in the brains and neurons of AD patients and APOE4 carriers [37,38], whereas APOE4 N2A cells expressed higher levels of fission and fusion proteins than APOE3 N2A cells [33].”
  • Neuronal APOE4 expression reduced the levels of mitochondrial respiratory complex subunits compared to APOE3 neurons.

    “Neuronal APOE4 expression reduced the levels of mitochondrial respiratory complex subunits compared to APOE3 neurons [32,33].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Conflicting counts of detected respiratory-complex subunits

    Minor

    The Results say 65 respiratory-complex subunits were detected, excluding cytochrome c, but the Discussion says 64 were detected.

  • Conflicting reductions in OXPHOS-dependent ATP production

    Minor

    The Results report a 33% lower OXPHOS ATP production rate in apoE4 cells, whereas the Discussion describes OXPHOS-dependent ATP production as 40-50% lower.

2 of 2

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. 10.1074/jbc.TM1117.000893 · DOI

Cited by

Sorted by citations

Authors
Orr, A. L., Kim, C., Jimenez-Morales, D., Newton, B. W., Johnson, J. R., Krogan, N. J., Swaney, D. L., & Mahley, R. W.
Affiliations
  • Gladstone Institutes (US)
  • Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA
  • University of California, San Francisco (US)
Corresponding author
Mahley, Robert W.
Venue
Journal of Alzheimer's Disease
Published
2019-04-08
Volume
68
Issue
3
Pages
991-1011
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2922380492
Cited by
103
References
124
Citations by year
2026: 21 · 2025: 17 · 2024: 12 · 2023: 16 · 2022: 10 · 2021: 15 · 2020: 8 · 2019: 4
FWCI
3.06
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • BrightFocus Foundation
  • Gladstone Institutes
  • National Institutes of Health
  • National Institute on Aging (R56AG057932)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
APOE ε4, Alzheimer's disease
MeSH terms
Adenosine Triphosphate, Animals, Energy Metabolism, Mitochondria, NAD, Neurons, Stress, Physiological, Reactive Oxygen Species, Proteome, Cell Line, Tumor, Mice, Apolipoprotein E4, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review